<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="e9481622-7cc6-418a-acb6-c5450daae9b0"><labelDrug name="ELIQUIS"><Normalization><mmtx cui="C3530466" preferredWord="Eliquis" semType="phsu"/></Normalization></labelDrug><generic name="apixaban"/><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.1" text="Drug Label for drug brand ELIQUIS, containing apixaban." type="negative"><entity charOffset="0:19" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand ELIQUIS," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:33" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.1.e.1" text="eliquis" type="Biomedical_Entity"><Normalization><mmtx cui="C3530466" phraseText="Drug Label for drug brand ELIQUIS," preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><entity charOffset="46:54" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.1.e.2" text="apixaban" type="Biomedical_Entity"><Normalization><mmtx cui="C1831808" phraseText="apixaban." preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.1.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.1.e.1"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.1.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.1.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.1.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.1.e.2"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.5" text="If anticoagulation with ELIQUIS must be discontinued for a reason other than pathological bleeding, coverage with another anticoagulant should be strongly considered see Dosage and Administration (2.4) and Warnings and Precautions (5.1)." type="negative"><entity charOffset="122:135" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.5.e.0" text="anticoagulant" type="Biomedical_Entity"><Normalization><mmtx cui="C3536711" phraseText="coverage with another anticoagulant" preferredWord="Anti-coagulant [EPC]" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="24:31" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.5.e.1" text="eliquis" type="Biomedical_Entity"><Normalization><mmtx cui="C3530466" phraseText="anticoagulation with ELIQUIS" preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.5.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.5.e.0"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.10" text="If anticoagulation with ELIQUIS must be discontinued for a reason other than pathological bleeding, coverage with another anticoagulant should be strongly considered. " type="negative"><entity charOffset="24:31" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.10.e.0" text="eliquis" type="Biomedical_Entity"><Normalization><mmtx cui="C3530466" phraseText="anticoagulation with ELIQUIS" preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><entity charOffset="122:135" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.10.e.1" text="anticoagulant" type="Biomedical_Entity"><Normalization><mmtx cui="C3536711" phraseText="coverage with another anticoagulant" preferredWord="Anti-coagulant [EPC]" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.10.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.10.e.1"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.26" text="An increased rate of stroke was observed during the transition from ELIQUIS to warfarin in clinical trials in patients with nonvalvular atrial fibrillation. " type="negative"><entity charOffset="79:87" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.26.e.0" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="to warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="68:75" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.26.e.1" text="eliquis" type="Biomedical_Entity"><Normalization><mmtx cui="C3530466" phraseText="from ELIQUIS" preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.26.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.26.e.0"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.27" text="If ELIQUIS must be discontinued for a reason other than pathological bleeding, consider coverage with another anticoagulant see Dosage and Administration (2.3)." type="negative"><entity charOffset="110:123" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.27.e.0" text="anticoagulant" type="Biomedical_Entity"><Normalization><mmtx cui="C3536711" phraseText="coverage with another anticoagulant" preferredWord="Anti-coagulant [EPC]" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="3:10" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.27.e.1" text="eliquis" type="Biomedical_Entity"><Normalization><mmtx cui="C3530466" phraseText="ELIQUIS" preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.27.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.27.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.30" lineNumber="51" text="Concomitant use of drugs affecting hemostasis increases the risk of bleeding. " type="irregular"><entity charOffset="19:45" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.30.e.0" text="drugs affecting hemostasis" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="Concomitant use of drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="68:76" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.30.e.1" text="bleeding" type="Specific_Interaction"/><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.30.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.30.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.29" text="ELIQUIS increases the risk of bleeding and can cause serious, potentially fatal, bleeding see Dosage and Administration (2.2) and Adverse Reactions (6.1)."><entity charOffset="0:7" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.29.e.0" text="ELIQUIS" type="Drug"><Normalization><mmtx cui="C3530466" phraseText="ELIQUIS" preferredWord="Eliquis" semType="phsu"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.30.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.30.e.0"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31" text="These include aspirin and other antiplatelet agents, other anticoagulants, heparin, thrombolytic agents, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitor, and nonsteroidal anti-inflammatory drugs (NSAIDs) see Drug Interactions (7.3)." type="negative"><entity charOffset="75:82" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.0" text="heparin" type="Biomedical_Entity"><Normalization><mmtx cui="C0019134" phraseText="heparin," preferredWord="Heparin" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="156:189" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.1" text="norepinephrine reuptake inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C1319313" phraseText="serotonin norepinephrine reuptake inhibitor," preferredWord="Norepinephrine re-uptake inhibitor" semType="phsu"/><RxNorm RxCui="7508"/></Normalization></entity><entity charOffset="32:51" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.2" text="antiplatelet agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0085826" phraseText="other antiplatelet agents," preferredWord="Antiplatelet Agents" semType="phsu"/><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="105:144" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.3" text="selective serotonin reuptake inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0360105" phraseText="selective serotonin reuptake inhibitors," preferredWord="Selective Serotonin Reuptake Inhibitors" semType="phsu"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="84:103" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.4" text="thrombolytic agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0016018" phraseText="thrombolytic agents," preferredWord="Fibrinolytic Agents" semType="phsu"/><RxNorm RxCui="4390"/></Normalization></entity><entity charOffset="195:231" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.5" text="nonsteroidal anti-inflammatory drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="nonsteroidal anti-inflammatory drugs (NSAIDs)" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="402125"/></Normalization></entity><entity charOffset="14:21" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.6" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="59:73" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.7" text="anticoagulants" type="Biomedical_Entity"><Normalization><mmtx cui="C0003280" phraseText="other anticoagulants," preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.1"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.0"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.3"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.4"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.5"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.6" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.0"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.7" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.0"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.1"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.1"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.4" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.1"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.5"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.6" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.1"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.7" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.1"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.3"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.4"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.5"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.6" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.7"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.4" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.3"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.5"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.6" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.3"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.7" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.3"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.4" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.5"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.6" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.4"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.7" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.4"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.6" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.5"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.7" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.5"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.6" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.31.e.7"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.35" text="A specific antidote for ELIQUIS is not available. " type="negative"><entity charOffset="24:31" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.35.e.0" text="eliquis" type="Biomedical_Entity"><Normalization><mmtx cui="C3530466" phraseText="A specific antidote for ELIQUIS" preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><entity charOffset="11:19" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.35.e.1" text="antidote" type="Biomedical_Entity"><Normalization><mmtx cui="C3536843" phraseText="A specific antidote for ELIQUIS" preferredWord="Antidote [EPC]" semType="phsu"/><RxNorm RxCui="930"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.35.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.35.e.0"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37" text="Protamine sulfate and vitamin K would not be expected to affect the anticoagulant activity of apixaban. " type="negative"><entity charOffset="0:17" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.0" text="protamine sulfate" type="Biomedical_Entity"><Normalization><mmtx cui="C0033602" phraseText="Protamine sulfate" preferredWord="Protamine Sulfate (USP)" semType="phsu, irda, aapp"/><RxNorm RxCui="236471"/></Normalization></entity><entity charOffset="22:31" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.1" text="vitamin k" type="Biomedical_Entity"><Normalization><mmtx cui="C0042878" phraseText="vitamin K" preferredWord="Vitamin K" semType="phsu, lipd, vita"/><RxNorm RxCui="604318"/></Normalization></entity><entity charOffset="68:81" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.2" text="anticoagulant" type="Biomedical_Entity"><Normalization><mmtx cui="C3536711" phraseText="the anticoagulant activity of apixaban." preferredWord="Anti-coagulant [EPC]" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="94:102" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.3" text="apixaban" type="Biomedical_Entity"><Normalization><mmtx cui="C1831808" phraseText="the anticoagulant activity of apixaban." preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.1"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.3"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.3"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.37.e.3"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38" text="There is no experience with antifibrinolytic agents (tranexamic acid, aminocaproic acid) in individuals receiving apixaban. " type="negative"><entity charOffset="70:87" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.0" text="aminocaproic acid" type="Biomedical_Entity"><Normalization><mmtx cui="C0002546" phraseText="aminocaproic acid" preferredWord="Aminocaproic Acids" semType="phsu, aapp"/><RxNorm RxCui="99"/></Normalization></entity><entity charOffset="53:68" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.1" text="tranexamic acid" type="Biomedical_Entity"><Normalization><mmtx cui="C0040613" phraseText="(tranexamic acid," preferredWord="Tranexamic Acid" semType="phsu, orch"/><RxNorm RxCui="10691"/></Normalization></entity><entity charOffset="114:122" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.2" text="apixaban" type="Biomedical_Entity"><Normalization><mmtx cui="C1831808" phraseText="apixaban." preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><entity charOffset="28:51" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.3" text="antifibrinolytic agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003304" phraseText="no experience with antifibrinolytic agents" preferredWord="Antifibrinolytic Agents" semType="phsu"/><RxNorm RxCui="934"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.0"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.0"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.1"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.38.e.2"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39" text="There is neither scientific rationale for reversal nor experience with systemic hemostatics (desmopressin and aprotinin) in individuals receiving apixaban. " type="negative"><entity charOffset="110:119" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.0" text="aprotinin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003641" phraseText="aprotinin" preferredWord="Aprotinin" semType="bacs, phsu, aapp"/><RxNorm RxCui="1056"/></Normalization></entity><entity charOffset="80:91" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.1" text="hemostatics" type="Biomedical_Entity"><Normalization><mmtx cui="C0019120" phraseText="experience with systemic hemostatics" preferredWord="Hemostatic Agents" semType="phsu"/><RxNorm RxCui="5220"/></Normalization></entity><entity charOffset="146:154" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.2" text="apixaban" type="Biomedical_Entity"><Normalization><mmtx cui="C1831808" phraseText="apixaban." preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><entity charOffset="93:105" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.3" text="desmopressin" type="Biomedical_Entity"><Normalization><mmtx cui="C0011701" phraseText="(desmopressin" preferredWord="desmopressin" semType="phsu, aapp, horm"/><RxNorm RxCui="3251"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.0"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.0"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.3"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.39.e.2"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.40" text="Use of procoagulant reversal agents such as prothrombin complex concentrate, activated prothrombin complex concentrate, or recombinant factor VIIa may be considered but has not been evaluated in clinical studies. " type="negative"><entity charOffset="77:118" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.40.e.0" text="activated prothrombin complex concentrate" type="Biomedical_Entity"><Normalization><mmtx cui="C0358606" phraseText="activated prothrombin complex concentrate," preferredWord="Factor VIII by-passing fraction products" semType="phsu"/><RxNorm RxCui="751543"/></Normalization></entity><entity charOffset="44:75" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.40.e.1" text="prothrombin complex concentrate" type="Biomedical_Entity"><Normalization><mmtx cui="C0072434" phraseText="such as prothrombin complex concentrate," preferredWord="prothrombin complex concentrates" semType="phsu, orch"/><RxNorm RxCui="1441688"/></Normalization></entity><entity charOffset="123:146" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.40.e.2" text="recombinant factor viia" type="Biomedical_Entity"><Normalization><mmtx cui="C0534191" phraseText="recombinant factor VIIa" preferredWord="recombinant FVIIa" semType="phsu, aapp"/><RxNorm RxCui="8410"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.40.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.40.e.0"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.40.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.40.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.40.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.40.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41" lineNumber="53" text="Activated oral charcoal reduces absorption of apixaban, thereby lowering apixaban plasma concentration see Overdosage (10)." type="regular"><entity charOffset="0:23" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.0" text="Activated oral charcoal" type="Substance"><Normalization><mmtx cui="C0001275" phraseText="Activated oral charcoal" preferredWord="Activated Charcoal" semType="phsu, orch"/><RxNorm RxCui="751543"/></Normalization></entity><entity charOffset="24:42" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.1" text="reduces absorption" type="Decrease_Interaction"/><entity charOffset="64:72|82:102" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.3" text="lowering plasma concentration" type="Decrease_Interaction"/><entity charOffset="73:81" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.5" text="apixaban" type="Drug"><Normalization><mmtx cui="C1831808" phraseText="apixaban plasma concentration" preferredWord="apixaban" semType="phsu"/><mmtx cui="C1831808" phraseText="apixaban plasma concentration" preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><entity charOffset="46:54" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.6" text="apixaban" type="Drug"><Normalization><mmtx cui="C1831808" phraseText="absorption of apixaban," preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.ddi.2"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.6" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.5" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.41.e.3" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47" lineNumber="62" text="Inhibitors of CYP3A4 and P-gp increase exposure to apixaban and increase the risk of bleeding. " type="regular"><entity charOffset="0:20" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.0" text="Inhibitors of CYP3A4" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:13|25:29" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.1" text="Inhibitors of P-gp" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="30:47" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.2" text="increase exposure" type="Increase_Interaction"/><entity charOffset="85:93" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.4" text="bleeding" type="Specific_Interaction"/><entity charOffset="51:59" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.6" text="apixaban" type="Drug"><Normalization><mmtx cui="C1831808" phraseText="P-gp increase exposure to apixaban" preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.2"><relations><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.ddi.2"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.4"><relations><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.6" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.2" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.6" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.2" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.47.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48" lineNumber="62" text="Inducers of CYP3A4 and P-gp decrease exposure to apixaban and increase the risk of stroke." type="regular"><entity charOffset="0:18" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.0" text="Inducers of CYP3A4" type="Drug_Class"><Normalization><RxNorm RxCui="993159"/></Normalization></entity><entity charOffset="28:45" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.1" text="decrease exposure" type="Decrease_Interaction"/><entity charOffset="49:57" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.3" text="apixaban" type="Drug"><Normalization><mmtx cui="C1831808" phraseText="P-gp decrease exposure to apixaban" preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><entity charOffset="83:89" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.4" text="stroke" type="Specific_Interaction"><Normalization><mmtx cui="C0038454" phraseText="the risk of stroke." preferredWord="Cerebrovascular accident" semType="dsyn"/></Normalization></entity><entity charOffset="0:11|23:27" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.6" text="Inducers of P-gp" type="Drug_Class"><Normalization><RxNorm RxCui="993159"/></Normalization></entity><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.ddi.2"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.3" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.6" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.3" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.1" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.6" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.0"/><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.6" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.3" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.48.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49" lineNumber="65" text="&lt;item&gt;Strong dual inhibitors of CYP3A4 and P-gp increase blood levels of apixaban: Reduce ELIQUIS dose to 2.5 mg or avoid concomitant use. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="90:97" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.8" text="ELIQUIS" type="Drug"/><antecedentEntity charOffset="73-81" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.3" text="apixaban" type="Drug"/></anaphoraRelation><entity charOffset="48:69" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.0" text="increase blood levels" type="Increase_Interaction"/><entity charOffset="6:47" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.2" text="Strong dual inhibitors of CYP3A4 and P-gp" type="Drug_Class"><Normalization><RxNorm RxCui="608507"/></Normalization></entity><entity charOffset="73:81" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.3" text="apixaban" type="Drug"><Normalization><mmtx cui="C1831808" phraseText="P-gp increase blood levels of apixaban" preferredWord="apixaban" semType="phsu"/><mmtx cui="C1831808" phraseText="P-gp increase blood levels of apixaban" preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><entity charOffset="83:89|98:102" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.4" text="Reduce dose" type="Increase_Interaction"/><entity charOffset="116:121" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.6" text="avoid" type="Caution_Interaction"/><entity charOffset="90:97" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.8" text="ELIQUIS" type="Drug"><Normalization><mmtx cui="C3530466" phraseText="ELIQUIS dose to 2.5 mg" preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.0"><relations><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.ddi.2"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.8"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.ddi.3"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.8"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.3" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.8" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.49.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51" lineNumber="67" text="&lt;item&gt;Simultaneous use of strong inducers of CYP3A4 and P-gp reduces blood levels of apixaban: Avoid concomitant use. " type="regular"><entity charOffset="26:60" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.0" text="strong inducers of CYP3A4 and P-gp" type="Drug_Class"><Normalization><RxNorm RxCui="608507"/></Normalization></entity><entity charOffset="85:93" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.1" text="apixaban" type="Drug"><Normalization><mmtx cui="C1831808" phraseText="blood levels of apixaban" preferredWord="apixaban" semType="phsu"/><mmtx cui="C1831808" phraseText="blood levels of apixaban" preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><entity charOffset="61:81" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.2" text="reduces blood levels" type="Decrease_Interaction"/><entity charOffset="95:100" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.4" text="Avoid" type="Caution_Interaction"/><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.ddi.2"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.1" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.51.e.2" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="6" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54" lineNumber="74" text="The dose of ELIQUIS should be decreased to 2.5 mg twice daily when it is coadministered with drugs that are strong dual inhibitors of CYP3A4 and P-gp, (e.g., ketoconazole, itraconazole, ritonavir, or clarithromycin) see Dosage and Administration (2.2) and Clinical Pharmacology (12.3)." type="regular"><entity charOffset="4:8|30:39" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.0" text="dose decreased" type="Increase_Interaction"/><entity charOffset="12:19" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.2" text="ELIQUIS" type="Drug"><Normalization><mmtx cui="C3530466" phraseText="The dose of ELIQUIS" preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><entity charOffset="93:149" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.3" text="drugs that are strong dual inhibitors of CYP3A4 and P-gp" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="coadministered with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="158:170" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.4" text="ketoconazole" type="Drug"><Normalization><mmtx cui="C0022625" phraseText="ketoconazole," preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="172:184" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.5" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="itraconazole," preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="186:195" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.6" text="ritonavir" type="Drug"><Normalization><mmtx cui="C0292818" phraseText="ritonavir," preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="200:214" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.7" text="clarithromycin" type="Drug"><Normalization><mmtx cui="C0055856" phraseText="clarithromycin" preferredWord="Clarithromycin" semType="orch, antb"/><RxNorm RxCui="21212"/></Normalization></entity><drugClassMembership drug="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.4" drugClass="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.3"/><drugClassMembership drug="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.5" drugClass="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.3"/><drugClassMembership drug="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.6" drugClass="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.3"/><drugClassMembership drug="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.7" drugClass="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.3"/><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.3" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.54.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55" lineNumber="75" text="In patients already taking ELIQUIS at a dose of 2.5 mg twice daily, avoid coadministration with strong dual inhibitors of both CYP3A4 and P-gp see Dosage and Administration (2.2) and Clinical Pharmacology (12.3)." type="regular"><entity charOffset="68:73" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55.e.0" text="avoid" type="Caution_Interaction"/><entity charOffset="96:142" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55.e.2" text="strong dual inhibitors of both CYP3A4 and P-gp" type="Drug_Class"><Normalization><RxNorm RxCui="608507"/></Normalization></entity><entity charOffset="27:34" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55.e.3" text="ELIQUIS" type="Drug"><Normalization><mmtx cui="C3530466" phraseText="ELIQUIS at a dose of 2.5 mg twice daily," preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55.e.0"><relations><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55.e.2" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.55.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="7" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57" lineNumber="79" text="Avoid concomitant use of ELIQUIS with strong dual inducers of CYP3A4 and P-gp (e.g., rifampin, carbamazepine, phenytoin, St. John's wort) because such drugs will decrease exposure to apixaban see Clinical Pharmacology (12.3)." type="regular"><anaphoraRelation><anaphoraEntity charOffset="183:191" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.2" text="apixaban" type="Drug"/><antecedentEntity charOffset="25-32" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.3" text="ELIQUIS" type="Drug"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="146:156" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.8" text="such drugs" type="Expression"/><antecedentEntity charOffset="38-77" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.5" text="strong dual inducers of CYP3A4 and P-gp" type="Drug_Class"/></anaphoraRelation><entity charOffset="162:179" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.0" text="decrease exposure" type="Decrease_Interaction"/><entity charOffset="183:191" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.2" text="apixaban" type="Drug"><Normalization><mmtx cui="C1831808" phraseText="exposure to apixaban" preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><entity charOffset="25:32" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.3" text="ELIQUIS" type="Drug"><Normalization><mmtx cui="C3530466" phraseText="concomitant use of ELIQUIS" preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><entity charOffset="38:77" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.5" text="strong dual inducers of CYP3A4 and P-gp" type="Drug_Class"><Normalization><RxNorm RxCui="608507"/></Normalization></entity><entity charOffset="0:5" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.6" text="Avoid" type="Caution_Interaction"/><entity charOffset="85:93" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.10" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="rifampin," preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="95:108" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.11" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="carbamazepine," preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><entity charOffset="110:119" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.12" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="phenytoin," preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="121:136" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.13" text="St. John s wort" type="Drug"><Normalization><mmtx cui="C0813171" phraseText="St. John's wort" preferredWord="ST. JOHN'S WORT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="669620"/></Normalization></entity><drugClassMembership drug="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.10" drugClass="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.5"/><drugClassMembership drug="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.11" drugClass="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.5"/><drugClassMembership drug="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.12" drugClass="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.5"/><drugClassMembership drug="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.13" drugClass="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.5"/><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.0"><relations><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.8"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.ddi.2"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.8" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.2" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.0" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.5" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.6" type="Caution_Interaction"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.58" text="7.3 Anticoagulants and Antiplatelet Agents" type="negative"><entity charOffset="23:42" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.58.e.0" text="antiplatelet agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0085826" phraseText="Antiplatelet Agents" preferredWord="Antiplatelet Agents" semType="phsu"/><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="4:18" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.58.e.1" text="anticoagulants" type="Biomedical_Entity"><Normalization><mmtx cui="C0003280" phraseText="7.3 Anticoagulants" preferredWord="Anticoagulants" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.58.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.58.e.0"/></sentence><sentence biomedicalEntities="5" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59" lineNumber="83" text="Coadministration of antiplatelet agents, fibrinolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding." type="irregular"><entity charOffset="118:126" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.0" text="bleeding" type="Specific_Interaction"/><entity charOffset="20:39" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.2" text="antiplatelet agents" type="Drug_Class"><Normalization><mmtx cui="C0085826" phraseText="Coadministration of antiplatelet agents," preferredWord="Antiplatelet Agents" semType="phsu"/><RxNorm RxCui="42539"/></Normalization></entity><entity charOffset="41:54" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.3" text="fibrinolytics" type="Drug_Class"><Normalization><RxNorm RxCui="934"/></Normalization></entity><entity charOffset="56:63" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.4" text="heparin" type="Drug"><Normalization><mmtx cui="C0019134" phraseText="heparin," preferredWord="Heparin" semType="bacs, phsu, carb"/><mmtx cui="C0770546" phraseText="heparin," preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="65:72" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.5" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="aspirin," preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="86:91" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.6" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="chronic NSAID use" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57" text="Avoid concomitant use of ELIQUIS with strong dual inducers of CYP3A4 and P-gp (e.g., rifampin, carbamazepine, phenytoin, St. John's wort) because such drugs will decrease exposure to apixaban see Clinical Pharmacology (12.3)."><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.57.e.2"/></ellipsisSentence><middleSentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.58" text="7.3 Anticoagulants and Antiplatelet Agents"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.6"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.5"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.4"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.3"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.5" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.6"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.4" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.6"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.6"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.4" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.5"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.5"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.2" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.6"/><pair ddi="true" e1="labelDrug" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.59.e.2"/></sentence><sentence id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60" text="APPRAISE-2, a placebo-controlled clinical trial of apixaban in high-risk post-acute coronary syndrome patients treated with aspirin or the combination of aspirin and clopidogrel, was terminated early due to a higher rate of bleeding with apixaban compared to placebo. " type="negative"><entity charOffset="124:131" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="treated with aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="154:161" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.1" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="the combination of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="238:246" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.2" text="apixaban" type="Biomedical_Entity"><Normalization><mmtx cui="C1831808" phraseText="with apixaban" preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><entity charOffset="51:59" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.3" text="apixaban" type="Biomedical_Entity"><Normalization><mmtx cui="C1831808" phraseText="a placebo-controlled clinical trial of apixaban" preferredWord="apixaban" semType="phsu"/><RxNorm RxCui="1364430"/></Normalization></entity><entity charOffset="166:177" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.4" text="clopidogrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0070166" phraseText="clopidogrel," preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.0"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.4"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.1"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.1" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.4"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.4" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.2"/><pair ddi="false" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.3" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.60.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62" lineNumber="85" text="In ARISTOTLE, concomitant use of aspirin increased the bleeding risk on ELIQUIS from 1.8% per year to 3.4% per year and the bleeding risk on warfarin from 2.7% per year to 4.6% per year. " type="regular"><entity charOffset="33:40" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.0" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="concomitant use of aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="72:79" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.1" text="ELIQUIS" type="Drug"><Normalization><mmtx cui="C3530466" phraseText="the bleeding risk on ELIQUIS" preferredWord="Eliquis" semType="phsu"/><RxNorm RxCui="1364436"/></Normalization></entity><entity charOffset="55:63" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.2" text="bleeding" type="Specific_Interaction"/><entity charOffset="124:132" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.4" text="bleeding" type="Specific_Interaction"/><entity charOffset="141:149" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.6" text="warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="the bleeding risk on warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="3:12" id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.7" text="ARISTOTLE" type="SPAN"/><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.ddi.1"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.2"><relations><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.1"/></relation><relation type="hasEvidence"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.ddi.2"><interaction trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.4"><relations><relation type="hasObject"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.6"/></relation><relation type="hasEvidence"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.1" evidence="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.7" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.2" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.0" e2="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.6" evidence="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.7" trigger="Dailymed.e9481622-7cc6-418a-acb6-c5450daae9b0.s.62.e.4" type="Specific_Interaction"/></sentence><positiveExamples number="22"/><negativeExamples number="78"/></document>